Clinical-stage biotechnology company developing therapies for cardiovascular conditions, with a focus on rapid, self-administered treatments for acute arrhythmias. Its lead candidate, etripamil, is a nasal spray being studied for the treatment of paroxysmal supraventricular tachycardia (PSVT) and ot...
No congressional trades have been disclosed for Milestone Pharmaceuticals Inc. (MIST) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.